Ticarcillin/clavulanic acid

Ticarcillin/clavulanic acid is a combination antibiotic consisting of Ticarcillin, a penicillin-type antibiotic, and clavulanic acid, a beta-lactamase inhibitor. This combination is used to treat a variety of bacterial infections by inhibiting the synthesis of bacterial cell walls.

Etymology

The name "Ticarcillin" is derived from the chemical structure of the drug, which includes a thienylcarboxylic acid moiety. The "clavulanic acid" part of the name comes from the compound's discovery in the organism Streptomyces clavuligerus.

Mechanism of Action

Ticarcillin works by inhibiting the final step of bacterial cell wall synthesis by binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall. Clavulanic acid, on the other hand, is a beta-lactamase inhibitor that helps prevent bacterial resistance to ticarcillin by inhibiting the enzyme that many bacteria produce to resist penicillin-type antibiotics.

Uses

Ticarcillin/clavulanic acid is used to treat a variety of bacterial infections, including those caused by Pseudomonas aeruginosa, Enterobacter species, and Staphylococcus aureus. It is also used in the treatment of intra-abdominal infections, skin and skin structure infections, and gynecologic infections.

Side Effects

Common side effects of ticarcillin/clavulanic acid include diarrhea, nausea, and vomiting. More serious side effects can include allergic reactions, blood disorders, and seizures.

Related Terms

• Antibiotic
• Bacterial cell wall
• Beta-lactamase
• Penicillin-binding protein
• Pseudomonas aeruginosa
• Enterobacter
• Staphylococcus aureus

Ticarcillin/clavulanic acid Resources
Latest articles Most recent articles Ongoing trials	Wikipedia